[Immunogenesis and hemostasis in patients with exacerbated chronic glomerulonephritis treated with thymalin].
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000293:Adolescent; D000328:Adult; D000917:Antibody Formation / Q000187:drug effects*; D002908:Chronic Disease; D004359:Drug Therapy, Combination; D005260:Female; D005921:Glomerulonephritis / Q000188:drug therapy / Q000276:immunology* / Q000503:physiopathology; D006487:Hemostasis / Q000187:drug effects*; D006801:Humans; D006973:Hypertension / Q000276:immunology / Q000503:physiopathology; D007111:Immunity, Cellular / Q000187:drug effects; D007676:Kidney Failure, Chronic / Q000276:immunology / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D009404:Nephrotic Syndrome / Q000276:immunology / Q000503:physiopathology; D013951:Thymus Hormones / Q000627:therapeutic use*
D000276:Adjuvants, Immunologic; D013951:Thymus Hormones; C032805:thymalin
Sostoianie immunogeneza i gemostaza u bol'nykh s obostreniem khronicheskogo glomerulonefrita, lechennykh timalinom.